Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Beta Bionics Inc shares valued at $63,192 were purchased by Mark Hopman on Dec 04 ’25. At $30.66 per share, Mark Hopman acquired 2,061 shares.
Also, Mensinger Mike sold 1,063 shares, netting a total of over 31,184 in proceeds. Following the sale of shares at $29.34 each, the insider now holds 90,752 shares.
Before that, Feider Stephen had sold 1,427 shares from its account. In a trade valued at $41,862, the Chief Financial Officer traded Beta Bionics Inc shares for $29.34 each. Upon closing the transaction, the insider’s holdings decreased to 1,427 shares, worth approximately $1.28 million.
Analysts at Goldman upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early October. As of June 16, 2025, Truist has initiated its “Buy” rating for BBNX. Earlier on June 12, 2025, Lake Street initiated its rating. Their recommendation was “a Buy” for BBNX stock.
Analyzing BBNX Stock Performance
On last trading session, Beta Bionics Inc [NASDAQ: BBNX] plunged -1.32% to $30.0. The stock’s lowest price that day was $29.56, but it reached a high of $31.51 in the same session. During the last five days, there has been a drop of approximately -2.79%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 29.20, which, if violated, would cause prices to drop to 28.41. In the upper region, resistance lies at 31.15. The next price resistance is at 32.31. RSI (Relative Strength Index) is 58.39 on the 14-day chart, showing neutral technical sentiment.
Is Beta Bionics Inc subject to short interest?
Stocks of Beta Bionics Inc saw a sharp steep in short interest on 2025-11-14 dropping by -0.6 million shares to 3.57 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 4.17 million shares. A decline of -16.71% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.89 of the overall float, the days-to-cover ratio (short ratio) decline to 4.89.
Which companies own the most shares of Beta Bionics Inc (BBNX)?
In terms of Beta Bionics Inc share price expectations, FactSet research, analysts set an average price target of 32 in the next 12 months, up nearly 5.26% from the previous closing price of $30.4. Analysts anticipate Beta Bionics Inc stock to reach 35 by 2025, with the lowest price target being 23. On May 30, 2025, Wolfe Research assigned a price target of “an Outperform” to the stock and initiated coverage with a $20.
